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Abstract: Experiments have been successfully performed
culminating in functional, vascularized, three-dimensional
cardiac muscle tissue. Past experience in tissue engineering
has led us to the understanding that cell seeding density
plays a critical role in the formation and function of both in
vitro and in vivo engineered tissues. Therefore, to improve
upon the mechanics of this model and to facilitate the
formation of myocardial tissue with improved functional
performance, we sought to optimize the seeding density of
cardiomyocytes in these constructs. Neonatal cardiac myo-
cytes were isolated from 2-day-old Fischer 344 rat hearts.
Silicone chambers containing fibrin gel were seeded with
varying numbers of cardiac cells (1, 5, 10, and 20 million).
Control chambers were prepared using fibrin gel alone. All
of the chambers were then implanted around the femoral
vessels of isogenic rats. Six constructs per cell seeding
density group were implanted. Histological and immuno-
histochemical evaluation was performed via hematoxylin
and eosin, von Gieson, and a-sarcomeric actin staining
protocols. Linear contractile force measurements were
obtained for each construct following 4 weeks of in vivo
implantation. After an implantation period of 4 weeks,
the newly formed cardiac constructs contained within the
chambers were harvested. The femoral vessels within the
constructs were found to be patent in all cases. With direct
electrical stimulation, the constructs were able to generate
an average active force that varied depending on their
seeding density. Constructs with seeding densities of 1, 5,
10, and 20 million cells produced an average active force of
208, 241, 151, and 108 mN, respectively. The control con-
structs did not generate any active force on electrical
stimulation. This study demonstrates the in vivo survival,
vascularization, organization, and function of transplanted
myocardial cells. It is also apparent that cell seeding density
plays a direct role in the force generation and mechanical
properties of these engineered constructs. Among different
groups using varying cell seeding densities, we found
that the group with 5 million cells generated maximum
active force. Key Words: Cardiac myocytes—Active
force—Cell seeding density—Implantation—Angiogenesis
—Tissue engineering.
Cardiac tissue engineering can play a potential
therapeutic role in the treatment of patients suffering
from a variety of cardiac disorders such as congestive
heart failure (CHF), myocardial infarction, or con-
genital disorders. The number of CHF patients alone
is on the rise, as is the cost related to their health
care. Cardiac myocytes have a limited ability to
regenerate. Attempts have been made to rejuvenate
infracted myocardial tissue by injecting myogenic
cells, replacing scarred myocardium with tissue-
engineered constructs, and to inject cells with geneti-
cally engineered DNA to constituently produce a
therapeutic protein.
Several strategies have been utilized to engineer
three-dimensional (3-D) cardiac tissue constructs.
Temperature-sensitive surfaces have been used to
assemble two-dimensional monolayers of cardiac
myocytes, which can then be stacked together to form
3-D cardiac muscle constructs (1–4). Synthetic scaf-
folds fabricated from polyglycolic acid (PGA) have
been used to generate 3-D constructs by seeding
them with neonatal cardiac myocytes (5–9). In
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addition, other researchers have investigated various
biodegradable gel systems consisting of gelatin algi-
nate and collagen (10–14).
Researchers in different fields of tissue engineer-
ing have tried to evaluate the role of cell seeding
density so as to eventually optimize their function-
ality while developing various tissue constructs
using scaffolds. Mauck et al. found that higher
seeding densities of chondrocytes on agarose hydro-
gels resulted in greater than a twofold increase in
material properties of resulting constructs (15). Kim
et al. optimized cell seeding and culture protocols
using biodegradable matrices of PGA fibers to engi-
neer smooth muscle tissue (16). They demonstrated
that an optimized experimental system can lead to
the development of smooth muscle tissue with cel-
lular and biochemical characteristics comparable
to native smooth muscle. Dar et al. attempted to
achieve 3-D high-density cardiac constructs with a
uniform cell distribution and found that the percent
cell yield in alginate scaffolds decreased at higher
seeding densities (17).
Our previous in vitro experiments with self-
assembled cardiac constructs indicated that higher
density does not necessarily yield better contractile
force (18).Also, in a previously described model of in
vivo myocardial tissue engineering, we have shown
that vascularization of these constructs allows signifi-
cant improvement in their functional properties (19).
In the present study, we aimed to improve the con-
tractile function of these cardiac constructs by
optimizing the cell seeding density. Such optimized
constructs could effectively replace scarred myocar-
dial tissue, and thus, restore function.
In our previous studies, we have developed a new
model to bioengineer functional 3-D heart muscle in
vivo (19). We isolated neonatal cardiac myocytes
from 2- to 3-day-old Fischer 344 (F344) rat hearts
and implanted silicone chambers containing fibrin
gel primary cardiac cells around the femoral vessels
in the groin area of adult rats. By 3 weeks, the cham-
bers were found to be filled with newly formed
“flaps” of tissue, supported by robust angiogenesis
from the femoral artery (FA) and vein. Evaluation
of the histologic and functional properties of these
tissue-engineered myocardial constructs demon-
strated the in vivo survival, vascularization, organi-
zation, and functionality of the transplanted
myocardial cells. During our initial studies, we
focused on model development and functional per-
formance of tissue constructs. In the current studies,
we focus on the role of initial cell seeding number on




Institutional approval for animal use was granted
by the University Committee for the Use and Care of
Animals in accordance with the “Guide for the Care
and Use of Laboratory Animals” (NIH publication
86-23, 1986). All materials were purchased from
Sigma (St. Louis, MO, USA) unless otherwise
specified.
Isolation of neonatal cardiac myocytes
The hearts were cut into fine pieces and suspended
in a dissociation solution (DS) which consisted of
0.32 mg/mL collagenase type II (Worthington Bio-
chemical Corporation, Lakewood, NJ, USA) and
0.6 mg/mL pancreatin dissolved in a buffer consisting
of 116 mM NaCl, 20 mM HEPES, 1 mM Na2HPO4,
5.5 mM glucose, 5.4 mM KCl, and 0.8 mM MgSO4.
The digestion of the cardiac tissue was carried out in
an orbital shaker for 5 min at 37°C. The supernatant
was then replaced with fresh DS, and the digestion
process was continued for an additional 30 min.
Following digestion, the supernatant was collected
and mixed with 5 mL of horse serum (Invitrogen
Corporation, Auckland, New Zealand) then centri-
fuged at 1500 rpm for 5 min. The cell pellet was then
resuspended in 5 mL of horse serum. The digestion
process was repeated an additional two to three times
with the addition of fresh DS to the original undi-
gested tissue. Cells from all the rounds of digestion
were pooled, centrifuged, and then suspended in
plating medium consisting of 335 mL Dulbecco’s
modified Eagle’s medium (DMEM), 85 mL M199,
25 mL fetal bovine serum, 50 mL horse serum, and
5 mL antibiotic–antimycotic solution (Invitrogen
Corporation). The total number of cells was deter-
mined using a hemocytometer. The process of tissue
digestion does not separate the two main cell sources,
namely myocardiocytes and fibroblasts. As a result,
both cell types are present in the final suspension, but
at a constant and uniform concentration.
Preparation of the chambers for implantation
Silicone tubing (Cole Parmer Instrument
Company, Vernon Hills, IL, USA), 3.1 mm inner
diameter and 4.7 mm outer diameter, and a wall
thickness of 0.79 mm was cut to a length of 10 mm,
making an internal volume of 80 mL. A longitudinal
slit was made down the length of each tube to allow it
to be opened lengthwise for placement around the
intact femoral vessels (Fig. 1).The previously isolated
cardiac myocytes were suspended in fibrin gel
(2340 mL of 3.5 mg/mL fibrinogen with 60 mL of
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200 U/mL of thrombin) at a concentration of 1, 5, 10,
and 20 million cells (cardiomyocytes plus cardiofibro-
blasts) per 80 mL of gel, respectively. The concentra-
tion of the cell suspension utilized was 12.5 ¥ 106 and
62.5 ¥ 106 cells/mL for the 1 and 5 million group,
respectively. For the 10 million group, we used a cell
concentration of 1.25 ¥ 108 cells/mL, and for the
20 million group we used 2.5 ¥ 108 cells/mL. Eighty
microliters of the cell and fibrin suspension was
pipetted into vertically oriented silicone tubes (six
chambers for each cell concentration) and allowed to
gel.Additionally, six control chambers were prepared
with fibrin gel alone.
Implantation and retrieval of chambers
Twenty-four cell-seeded chambers and six control
chambers were implanted. Adult F344 rats, weighing
approximately 250–300 g, were used as recipients.
The animals were anesthetized by an intraperitoneal
injection of 0.5 mL of sodium pentobarbital (Abbott
Laboratories, Chicago, IL, USA). The groins were
clipped of hair and sterilely prepped and draped.
The femoral vessels were exposed through tangential
incision made in the groin.With the aid of a dissecting
microscope, the FA and femoral vein (FV) were
separated from their surrounding tissue and ac-
companying femoral nerve. Several small vascular
branches to the thigh musculature were cauterized to
isolate the femoral vessels from the inguinal ligament
to the branch point of the epigastric vessels. The
previously prepared cardiomycoyte/fibrin gel-filled
tubes were placed around the femoral vessels, by
passing the intact vascular pedicle through the slit in
the side of the silicone tubes (Fig. 1A). The wounds
were closed in two layers, and the animals were
allowed to recover.
After 4 weeks, the rats were reanesthetized and the
chambers were isolated. Patency of the vascular
pedicles was confirmed by visual observation of
blood flow through the vessels. The FA, FV, and all
soft tissue attachments were divided at the proximal
and distal ends of the chambers. The silicone tubes
were opened along their longitudinal slit, and the
tissues within them were removed and pinned to
35 mm tissue culture plates coated with polydimeth-
ylsiloxane substrate (Dow Chemical Corporation,
Midland, MI, USA). Culture medium consisting of
365 mL DMEM, 100 mL M199, 35 mL fetal bovine
serum, and 5 mL antibiotic–antimycotic (Invitrogen
Corporation) was added to the plates. The myocar-
dial characteristics and contractility of the tissues
were determined as described as follows.
Functional assessment
The functional capability of the cardiac construct
was measured by active contractile force production.
Immediately upon explantation, the constructs were
placed in a 35 mm culture dish with DMEM growth
medium. The method for evaluating the active
contractile force of engineered muscle has been
described in detail in previous work (20,21). Briefly,
the constructs were placed in culture media at 37°C,
between parallel platinum electrodes. One end of the
construct was fixed to the plate by a pin and the other
end of the construct was connected to a custom-built
optical force transducer. The data I/O board was
controlled by a custom-made LabVIEW software
program (National Instruments, Austin, TX, USA)
running on a personal computer. The LabVIEW and
data I/O board generated output voltage signals
which were amplified and delivered to the construct
via platinum electrode wires lying parallel to the con-
structs, one electrode on either side of the construct.







FIG. 1. Implantation of cardiac myocytes. (A) Implantation
model: silicone chamber (SC) containing fibrin gel and cardiac
myocytes implanted in the groin region around the FA, FV, and
inguinal ligament (IL). (B) Cardiac construct after explantation.
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session, the spontaneous contractions of the con-
structs were recorded in the absence of any electrical
stimulation. This was followed by field stimulation to
generate linear twitch contractile force.The following
stimulation pulse parameters were utilized: a single
bipolar, balanced, square wave pulse of 7 V ampli-
tude and 1.2 ms duration.
Assessment of cardiac muscle actin and
collagen contents
The cardiac muscle actin in the engineered cardiac
tissue was visualized and evaluated by an immuno-
fluorescence (IF) staining technique using antibodies
raised against a-sarcomeric actin. A standard col-
lagen staining method using von Gieson stain and
light microscopy was used to identify and evaluate
the collagen content. Constructs were fixed in a 4%
paraformaldehyde solution for 4 h, rinsed in 70%
ethanol, and stored in 70% ethanol until use. The
constructs were prepared using a graded ethanol
process with an automated tissue processor
(Shandon Hypercenter XP, Thermo Electron,
Waltham, MA, USA) for 7 h and 36 min. The con-
structs were then paraffin embedded. The paraffin-
embedded samples were sectioned at 7 mm on a
microtome processor and placed on ProbeOn Plus
slides (Fisher Scientific Company, Pittsburgh, PA,
USA) for immunohistochemistry. For IF staining, the
constructs were incubated with normal goat serum
blocking solution for 30 min, followed by mouse
monoclonal anti-a-sarcomeric actin (1:500, Sigma)
primary antibody for 1 h. Finally, they were incubated
with goat FITC conjugated anti-mouse IgG (1:150,
Sigma) for 30 min. Consequently, the cardiac muscle
actins were visualized in the tissue by using an IF
microscope. Digital images were taken by an
Olympus DP 70 digital camera (Center Valley, PA,
USA) and associated software through an Olympus
BX 51 microscope with the 10¥ objective lens. To
demonstrate the whole tissue, a single image or two
overlapping images were superimposed using Adobe
Photoshop software (Adobe Systems, San Jose, CA,
USA). Each whole tissue image was converted to
a digital 8-bit, gray-scale image, and the brightness
was adjusted until the mean value of negative tissue
background equaled a predefined value of 25 (scale
0–255) using Adobe Photoshop software (Adobe
Systems).This image was then analyzed using ImageJ
software, version 1.34s (National Institutes of Health,
Bethesda, MD, USA, download site http://rsb.info.
nih.gov/ij/). First, the image was manipulated to
remove background fluorescence via a threshold
function. Only cardiac a-sarcomeric actin that was
fluorescent above the defined threshold level of 60,
on a 0–255 black-to-white scale, remained for
analysis. The immunopositive region was measured
and converted to an area in square millimeters. Next,
the total tissue area was measured and the results
were expressed as the percent area of fluorescently
stained tissue to total tissue area.
Collagen fibers were identified by preparing the
sectioned tissue with von Gieson stain. The digital
images were taken in the bright field mode from the
same microscope image system at the 4¥ magnifica-
tion of the objective lens to demonstrate the whole
tissue area.The photo was converted to a digital 8-bit,
gray-scale image. The brightness was adjusted until
the mean value of noncollagen background tissue
equaled the predefined value of 120 (scale 0–255)
using Adobe Photoshop software (Adobe Systems).
This image was then analyzed using ImageJ software,
version 1.34s in a similar fashion stated earlier. In the
case of collagen, the threshold value that represented
positive staining of collagen fibers was defined as
a value less than 100 (scale 0–255). The collagen
content fraction was determined as the percent area
of collagen to total tissue area.
RESULTS
After a period of 4 weeks of in vivo implantation,
all 30 chambers were explanted. They were found
to be filled with viable tissue occupying the entire
volume of the chamber (Fig. 1B).The femoral vessels
had incorporated into the newly formed tissue, and
remained intact and patent. Each of the experimental
constructs exhibited spontaneous contractions fol-
lowing explantation and placement in culture dishes
filled with growth media at 37°C. The stimulated
contractile force of each of the explanted constructs
was measured as per protocol. The twitch force of
the explanted constructs varied with cell density
(Fig. 2A), while control constructs did not generate
any measureable active force in response to electrical
stimulation (Fig. 2B). The average twitch force gen-
erated by the constructs with cell seeding densities of
1, 5, 10, and 20 million cells was found to be 208, 241,
151, and 108 mN (Fig. 3). Tissues harvested out of the
control chamber on explantation did not exhibit any
spontaneous contraction, and there was no active
force generation on electrical stimulation.
Histological evaluation provided an insight into
the cellular organization within the 3-D tissue
constructs. Staining with hematoxylin and eosin
(H&E) revealed the presence of a large number of
viable cells around the femoral vessels within the
explanted chamber (Fig. 3). In addition, intact
femoral vessels were observed within the 3-D
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tissue construct. A large number of newly formed
capillaries, with the presence of intraluminal erythro-
cytes, were also easily identifiable in the H&E stains
of both the experimental and control constructs (Fig.
4). Staining for a-sarcomeric actin showed the distri-
bution of the cardiomyocytes. The cardiac cells were
predominantly distributed in a concentric ring of
newly formed cellular material around the femoral
vessels (Fig. 5). The percentages of a-sarcomeric
actin positive area per total construct tissue area with
cell seeding densities of 1, 5, 10, and 20 million cells
were 13.97  2.73, 18.88  1.43, 16.95  1.11, and
14.10  4.75% of total construct area, respectively
(N = 4 and P = 0.59) (Fig. 6). This finding demon-
strates that the constructs with a cell seeding density
of 5 million cells tend to have the highest percentage
of actin, which corresponds with the active force data.
There was no positive actin staining in the control
constructs. There was also a significant amount of
collagen present as identified by von Gieson staining.
Large collagen fibers were concentrated closer to the
femoral vessels. Smaller collagen fibers were found to
be distributed throughout the concentric ring of cel-
lular material. The percentages of collagen area per
total construct tissue area with cell seeding densities
of 1, 5, 10, and 20 million cells were 21.45  4.03,
14.67  1.02, 15.37  3.29, and 9.63  1.04% of total
construct area, respectively (N = 4 and P = 0.08)
(Fig. 7).
DISCUSSION
Both cell transplantation and bioengineered
cardiovascular tissues represent novel biologic
A
B
FIG. 2. Representative twitch force tracings are shown.
Explanted cardiac constructs were stimulated between parallel
platinum electrodes, and the twitch force was recorded using an
optical force transducer. (A) Explanted cardiac construct with 5
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FIG. 3. In vivo cardiac construct active force. Graph showing the
relationship between the cell seeding density and force gener-
ated by in vivo tissue-engineered myocardial constructs.
FIG. 4. Histology of the constructs. (A) H&E staining of a section
through the center of a construct demonstrates the presence of a
large number of cells distributed throughout the tissue construct.
(B) H&E staining also shows the presence of vascular channels
within the tissue construct.
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approaches which can potentially benefit the patients
with myocardial infarction, heart failure, and con-
genital heart diseases.The role of cell transplantation
including seeding muscle cells such as cardiomyo-
cytes or skeletal myoblasts as a means to repair
damaged myocardium has been investigated. Seeding
of noncardiac cells such as smooth muscle cells,
endothelial cells, or bone marrow stem cells has been
attempted to promote therapeutic angiogenesis and
to induce differentiation of endogenous progenitors
into myocytes in the infarct scar. Additionally, skel-
etal myocytes with genetically altered DNA have
been produced which constituently manufacture pro-
teins that stimulate angiogenesis. These cells have
been injected into heart tissue and have delivered
therapeutic proteins such as recombinant insulin-like
growth factor-1 and recombinant vascular endothelial
growth factor. Menasche et al. found that adult stem
cells (myogenic or marrow derived) fail to electrome-
chanically integrate within the recipient heart (22).
They suggested that a true cardiomyogenic pheno-
type, such as cardiac stem cells or a cardiac precom-
mitted embryonic stem cell, may have the potential to
ensure a true regeneration of dead myocardium.
Elmadbouh et al. proposed the use of autologous
mesothelial cells for cell therapy in the reversal of
infarct scar modeling (23). Among bioengineered
cardiovascular tissues, both scaffold-based and self-
FIG. 5. Staining for collagen and actin.
Serial cross sections of the cardiac con-
struct stained in H&E (A, D). A and V
denoting the location of femoral artery (A)
and vein (V) within the construct. von
Gieson staining (B, E) demonstrates the
collagen fiber distribution. Predomi-
nant collagen presence is noted around
the femoral vessels. Immunofluorescent
a-sarcomeric actin staining (C, F) demon-
strating the concentric distribution of the
cardiac cells around the femoral vessels
within the construct. Histological sections
presented here are for constructs gener-



















FIG. 6. Percentage area of a-sarcomeric actin-stained cardio-





















FIG. 7. Percentage area of collagen content present in con-
structs with varying cell seeding densities.
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assembled models of cardiac muscle constructs have
been employed. In addition, both in vitro and in
vivo techniques have been used to engineer these
constructs. In our present work, we were able to
reproduce our initial self-assembled model for in vivo
cardiac tissue engineering.Additionally, we were able
to study and understand the 3-D organization of
cardiac cells within the in vivo formed constructs. We
believe that factors such as cell seeding density, total
implantation time, size of the chamber used, and
fibrin degradation kinetics can influence the forma-
tion of these in vivo tissue-engineered constructs in
terms of their ultimate functionality. In the present
study, we aimed to find the optimal cell seeding
density that would provide constructs with maximum
contractile functionality. There have not been any
published studies to evaluate the correlation between
cell seeding density and resultant active force while
forming self assembled in vivo tissue-engineered
cardiac constructs.
Our initial in vitro experiments (18) suggested that
higher cell seeding density does not result in a supe-
rior functioning construct (Fig. 8).The present in vivo
study confirms these same results and demonstrates
that the average active force generated by constructs
with a seeding density of 5 million cells was higher as
compared to constructs with seeding densities of 1,
10, or 20 million cells. Interestingly, quantification of
positively stained actin also paralleled the force char-
acteristics (Fig. 9). This suggests that the active force
generated by these constructs is directly proportional
to the quantity of viable cardiac tissue present within
them.At low seeding densities of 1 million cells, there
was less viable cardiac tissue as measured by actin
content and less force produced. By increasing the
seeding density to 5 million cells, the quantity of
cardiac tissue, although not statistically significant,
increased, as did force production. Once seeding
density was increased to greater than 5 million cells,
cell density had a detrimental effect as seen by less
force produced and decreased actin content in these
constructs.
This suggests that although a high cell number was
utilized for construct formation, there was an upper
limit for cardiac cell viability.We speculate that a high
degree of cell death was associated with the higher
seeding density, thereby limiting the functional
outcome of the explanted constructs. The collagen
data also supported this notion. We found that the
collagen content parallels both the force production
and actin content at higher seeding densities. The
collagen content decreased as the cell seeding density
increased in the same manner as did the actin content
at high seeding density. We speculate that this reduc-
tion of actin and collagen in the high-density seeded
constructs may be due to cellular death of the trans-
planted cardiomyocytes and cardiofibroblasts sec-
ondary to the limited space available. Our results
suggest that lower seeding densities of 5 million cells
support the formation of more functional cardiac
muscle due to high cardiac cell viability. Our study is,
however, limited by the small sample size utilized. A
total of six constructs were generated for each
seeding density, and the constructs utilized for func-
tional and histological testing. Although the results
do provide a basis for the relationship between
seeding density and functional performance of the
tissue constructs, a larger sample size would have
resulted in reduced bias of the data.
In summary, we have been able to optimize one
of the important variables of our in vivo tissue-
engineered myocardial constructs, and demonstrate
the effect of cell seeding density on resultant





























FIG. 8. Graph showing the relationship between the cell seeding

































FIG. 9. Relationship between a-sarcomeric actin-stained
cardiac tissue and respective generated force in constructs with
varying cell seeding densities. Values for percentage actin have
been multiplied by a factor of 10.
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tissue-engineered, 3-D constructs may have a poten-
tial role in the replacement and repair of infarcted
myocardium.
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